Molecular Partners and Novartis believe in the success of DARPins.
Omicron
Posted inCOVID-19, Infections, Research
Eliminating Health Disparities Is Key to Ending Pandemic
Misinformation, populism, and self-interest keep the COVID-19 that has enslaved the planet.
Posted inCOVID-19, Infections, Research
Three Billion Omicron Cases
Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.
Posted inCOVID-19, Infections, New Drugs, Regulatory
MIR 19: Surprising New Drug to Treat Coronavirus
A Russian drug for COVID-19 has adopted a powerful RNA interference technology.
Posted inCOVID-19, Infections, Research
Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
Posted inCOVID-19, Infections, Research
Universal Coronavirus Vaccine
The biotechnology industry must come up with a comprehensive defense against all coronaviruses.
Posted inClinical Trials, COVID-19, Infections
Sotrovimab Is Effective Against Omicron Variant of Coronavirus
A monoclonal antibody developed by GlaxoSmithKline and Vir Biotechnology successfully counteracts a new strain of SARS-CoV-2.